MUC1 and MUC5AC implication in Tunisian colorectal cancer patients.

Turk J Med Sci

Laboratory of Colorectal Cancer Research UR12SP14, Mongi Slim Hospital, La Marsa, Tunisia

Published: February 2021

Background/aim: Mucins, such as MUC1 and MUC5AC, are known for their protective and moisturizing role in intestinal epithelium. Their expression is tightly controlled given their essential role in normal tissue homeostasis, whereas their deregulation leads to chronic inflammation, and even cancer. This study aimed to assess the expression profiles of MUC1 and MUC5AC and their implications in colorectal carcinogenesis.

Materials And Methods: A retrospective study of 202 patients who underwent colorectal cancer (CRC) surgery was conducted. The expression of MUC1 and MUC5AC was investigated by immunohistochemistry and reverse-transcription polymerase chain reaction (RT-PCR). Statistical analysis of mucin expression pattern, as well as the clinicopathological criteria of the patients, was performed using the chi-square test, survival curves were plotted using the Kaplan—Meier product-limit method, and differences between the survival curves were tested using the log-rank test.

Results: The expression of both mucins was abnormally high in the tumor tissues for both mRNA and protein. MUC1 expression was correlated with advanced cancer stages and lymph node metastases for both the mRNA (P < 0.016 and P < 0.002, respectively) and protein level (P < 0.006 and P < 0.001, respectively). However, MUC5AC expression did not pinpoint any significant association between the clinicopathological criteria, but patients who expressed MUC5AC showed an increase in overall survival (P < 0.009).

Conclusion: The expression of MUC1 might be a poor prognostic biomarker in CRC and could play a role in tumor transformation and metastasis. However, MUC5AC expression might be a good prognostic in the Tunisian cohort.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991860PMC
http://dx.doi.org/10.3906/sag-2003-29DOI Listing

Publication Analysis

Top Keywords

muc1 muc5ac
16
expression
9
colorectal cancer
8
expression muc1
8
clinicopathological criteria
8
criteria patients
8
survival curves
8
muc5ac expression
8
muc1
6
muc5ac
6

Similar Publications

Article Synopsis
  • - Mucins are important molecules in the gastrointestinal tract, classified into membrane-associated types and secreted types, with limited knowledge regarding their presence in prenatal development.
  • - In this study, mucin-secreting cells were identified in the developing rabbit esophagus, which are absent in adults, using various staining techniques to analyze their characteristics.
  • - The findings suggest that these mucous cells are modified epithelial cells originating from the basal layer and may play a role in esophageal development, indicating the need for further research on their functions.
View Article and Find Full Text PDF

Background And Aims: Mucosal healing is considered as a key therapeutic endpoint in inflammatory bowel diseases (IBD) and comprises endoscopic improvement of inflammation without taking barrier healing into account. Mucins are critical components of the mucosal barrier function that give rise to structurally diverse isoforms. Unraveling disease-associated mucin isoforms that could act as an indication for barrier function would greatly enhance IBD management.

View Article and Find Full Text PDF

Ectoine Enhances Mucin Production Via Restoring IL-13/IFN-γ Balance in a Murine Dry Eye Model.

Invest Ophthalmol Vis Sci

June 2024

Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, United States.

Article Synopsis
  • A study looked at how a natural substance called ectoine can help protect the eyes of mice from dry eye disease.
  • Mice with dry eyes showed damage, but when treated with ectoine, their eye conditions got much better.
  • Ectoine helped fix the balance of special proteins in the eyes, which means it could be useful for people with dry eyes too! *
View Article and Find Full Text PDF

Enhancing pulmonary delivery and immunomodulation of respiratory diseases through virus-mimicking nanoparticles.

J Control Release

August 2024

Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14040-900, Brazil. Electronic address:

This study introduces the nanobromhexine lipid particle (NBL) platform designed for effective pulmonary drug delivery. Inspired by respiratory virus transport mechanisms, NBL address challenges associated with mucus permeation and inflammation in pulmonary diseases. Composed of low molecular weight polyethylene glycol-coated lipid nanoparticles with bromhexine hydrochloride, NBL exhibit a size of 118 ± 24 nm, a neutral zeta potential, osmolarity of 358 ± 28 mOsmol/kg, and a pH of 6.

View Article and Find Full Text PDF

Prognostic Impact of Mucin Expression in Curatively Resected Ampulla of Vater Cancer.

Cancers (Basel)

June 2024

Department of Pathology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan 49241, Republic of Korea.

Article Synopsis
  • The majority of patients (98.5%) showed positive MUC1 expression, while MUC5AC demonstrated a significant association with overall survival and lymph node metastasis.
  • MUC5AC expression could serve as a potential biomarker for evaluating prognosis and guiding treatment decisions in AoV cancer patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!